Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
Trending News
More News >
News
Enterprise Solutions
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Calculators
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
MLYS
Stock Latest News
Ratings
Buy Rating Affirmed for Lorundrostat Amid Positive Trial Results and Market Potential
9d ago
MLYS
Premium
The Fly
Mineralys Therapeutics price target raised to $42 from $30 at H.C. Wainwright
9d ago
MLYS
Premium
Market News
3 Best Stocks to Buy Now, 4/1/2025, According to Top Analysts
10d ago
DAVE
ENVX
Premium
Company Announcements
Mineralys Therapeutics Unveils Promising Trial Results for Lorundrostat
11d ago
8K
MLYS
Premium
Market News
3 Best Stocks to Buy Now, 3/31/2025, According to Top Analysts
11d ago
TLN
BRZE
Premium
The Fly
Mineralys Therapeutics presents results from Phase 2 Advance-HTN trial
11d ago
MLYS
Premium
Ratings
Promising Clinical Trial Results and Safety Profile of Lorundrostat Support Buy Rating for Mineralys Therapeutics
12d ago
MLYS
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
20d ago
INO
ARCT
Premium
Ratings
Buy Rating Justified for Mineralys Therapeutics, Inc. Due to Promising Study Results and Manageable Safety Profile
21d ago
MLYS
Premium
The Fly
Largest borrow rate increases among liquid names
25d ago
LAC
QSR
Premium
The Fly
Mineralys Therapeutics announces data from Phase 2 Advance-HTN trial
25d ago
MLYS
Premium
The Fly
Largest borrow rate increases among liquid names
28d ago
WW
FRO
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
29d ago
AEON
APRE
Premium
The Fly
Mineralys Therapeutics 12.96M share Secondary priced at $13.50
1M ago
MLYS
Premium
The Fly
Mineralys Therapeutics announces $250M common stock offering
1M ago
MLYS
Premium
Ratings
Buy Rating Affirmed for Mineralys Therapeutics, Inc. Due to Promising Lorundrostat Study Outcomes
1M ago
MLYS
Premium
Ratings
Promising Potential of Lorundrostat Drives Buy Rating for Mineralys Therapeutics, Inc.
1M ago
MLYS
Premium
Company Announcements
Mineralys Therapeutics Reports Positive Phase 3 Trial Results
1M ago
8K
MLYS
Premium
The Fly
Mineralys Therapeutics announces results from Launch-HTN, Advance-HTN trials
1M ago
MLYS
Premium
Ratings
Buy Rating for Mineralys Therapeutics, Inc. Driven by Lorundrostat’s Potential in Hypertension Treatment
1M ago
MLYS
Premium
Market News
3 Best Stocks to Buy Now, 2/26/2025, According to Top Analysts
1M ago
BABA
BLZE
Premium
Company Announcements
Mineralys Therapeutics Highlights Positive Earnings Call
2M ago
MLYS
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
